
Finland · Medical Device
Revenio provides enterprise-scale e-marketing software to capture customer attention, loyalty and value.
PrivateFor profit
What the record says about Revenio as a customer or partner.
Set against 62 Medical Device companies in Finland. The ring marks the typical peer.
Across all 5.9M companies: larger than 33% of those with a size listed; older than 68% of those with a founding year; website ranked #7,774,288 in the world, about 716 visits a month. 31 people list it on LinkedIn, and 2,084 follow it.
Revenio is a global provider of comprehensive eye care diagnostic solutions. The group offers fast, user-friendly, and reliable tools for diagnosing glaucoma, diabetic retinopathy, and macular degeneration (AMD). Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as software solutions under the iCare brand. In 2024, the Group’s net sales totaled EUR 103.5 million, with an operating profit of EUR 25.0… Read all
Revenio is a global provider of comprehensive eye care diagnostic solutions. The group offers fast, user-friendly, and reliable tools for diagnosing glaucoma, diabetic retinopathy, and macular degeneration (AMD). Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as software solutions under the iCare brand. In 2024, the Group’s net sales totaled EUR 103.5 million, with an operating profit of EUR 25.0 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V. Revenio on kansainvälisillä markkinoilla toimiva kokonaisvaltaisten silmien hoidon diagnostiikkaratkaisuiden toimittaja. Konserni tarjoaa nopeita, helppokäyttöisiä ja luotettavia työkaluja glaukooman, diabeettisen retinopatian ja silmänpohjan rappeuman diagnosointiin. Revenio-konsernin silmän diagnostiikkaratkaisuihin kuuluvat iCare-brändin alla silmänpaineen mittauslaitteet (tonometrit), silmänpohjan kuvantamislaitteet, perimetrit ja ohjelmistoratkaisut. Revenio-konsernin liikevaihto vuonna 2024 oli 103,5 miljoonaa euroa ja liiketulos 25,0 miljoonaa euroa. Revenio Group Oyj:n osake on listattu Nasdaq Helsinki Oy:ssä kaupankäyntitunnuksella REG1V.
InternetMarketingSoftware
What the source datasets report. We have not watched these rounds ourselves.
$16M
raised in total across 1 round
Last raised Mar 2000, 26 years ago
Where it sits in its group, and the deals it has done.
Who started it and how it trades.
Everything the source datasets list about Revenio, field by field. Contact details are held but never shown.
The company7 fields
Where4 fields
Size and reach5 fields
Funding, as listed8 fields
Corporate family1 field
About this record2 fields
Growth, as the source summarises it
Revenio Group Oyj may be growing as the company has surpassed full-year earnings expectations for 2023, which is a strong indicator of financial performance and often reflects increased revenue and profitability. Analysts have also provided a valuation for the company's shares post-results, suggesting a recognition of the company's value in the market following its financial achievements. Furthermore, the concern about the company's debt usage implies that Revenio Group Oyj is being scrutinized for its financial strategies, which often occurs when a company is expanding and investing.
62 Medical Device companies in Finland, filtered by size, age and reach, ready to export with emails on Pro.